← All startups
Scribe Therapeutics
Portfolio of genetic medicines for cardiometabolic disease using proprietary, engineered gene editing and epigenetic silencing platforms
Latest roundFunding roundOct 1, 2018
Team32
NameLocationLinksContact
Benjamin L. Oakes
Chief Executive Officer
Berkeley, California, United States
—
Brett T. Staahl
Co-Founder
—
—
David F. Savage
Co-Founder
—
—
David Parrot
Chief Financial Officer
Mill Valley, California, United States
—
Jennifer A. Doudna
Co-Founder
—
—
Svetlana Lucas
Chief Operating Officer
San Francisco, California, United States
—
George Manning
Vp
—
—
Richard Hector
Vice President
San Francisco, California, United States
—
Shilpa Shroff
VP
—
—
Vera Switek
VP
—
—
Alison Lin
Director Of Fp a
—
—
Andrew Meadows
Senior Director
—
—
Behzad Aghazadeh
Director
—
—
Carl L. Gordon
Director
—
—
Christie Sze
Associate Director
—
—
Duyen Chau
Director of Quality
—
—
Ed Sterling II
Director
—
—
Elena Smekalova
Associate Director
—
—
Eugene Surenkov
Procurement Director
—
—
Farah Bardai
Senior Director
—
—
Ioana L. Aanei
Director
—
—
Jason Wang
Sr Director
—
—
Jie Wang
Associate Director
—
—
Keith Szulwach
Associate Director
—
—
Larry Dobson
Director-facilities
—
—
Leon Chu-Hsiang Yu
Associate Director
—
—
Michelle Eggers
Senior Director
—
—
Oleh Krupa
Associate Director
—
—
Timothy Ingallinera
Director
—
—
Matty Morin
Senior Manager
—
—
Jenny Malecki
Executive Assistant To Chief Executive Officer
—
—
David T.
Development Team Lead
—
—